天津医药 ›› 2021, Vol. 49 ›› Issue (8): 852-856.doi: 10.11958/20210274

• 临床研究 • 上一篇    下一篇

术中目标导向的晶体液或胶体液输注对胃肠道术后并发症的影响

金菊英,刘丹,闵苏   

  1. 重庆医科大学附属第一医院麻醉科(邮编400016)
  • 收稿日期:2021-01-29 修回日期:2021-04-02 出版日期:2021-08-15 发布日期:2021-08-19
  • 通讯作者: 金菊英(1977),女,博士,副主任医师,主要从事围术期液体治疗、加速康复外科相关研究。E-mail:juyingjin@hotmail.com E-mail:ms1068@outlook.com
  • 基金资助:
    重庆市科委科技惠民计划项目(cstc2015jcsf10008)

Effects of crystalloid or colloid for intraoperative goal-directed fluid therapy on postoperative complications in patients undergoing gastrointestinal surgery

JIN Ju-ying, LIU Dan, MIN Su△   

  1. Department of Anesthesiology, the First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China △Corresonding Author E-mail: ms1068@outlook.com
  • Received:2021-01-29 Revised:2021-04-02 Published:2021-08-15 Online:2021-08-19

摘要: 目的 比较术中以晶体液或胶体液作为目标导向液体治疗对胃肠道手术患者术后并发症的影响。方法 选择拟在全身麻醉下行择期开放或腹腔镜胃肠道手术的患者362例,采用随机数字表法分为晶体液组180例和胶体 液组182例。所有患者入手术室后予乳酸钠林格注射液行基础输注,术中采用FloTrac/Vigileo系统监测每博量(SV), 以SV最大化为目标,2组分别予晶体液或胶体液行目标导向液体治疗。记录术中输液出入量和血管活性药物使用 情况。收集患者术后30 d内并发症发生率、病死率、住院时间及费用等资料。结果 胶体液组快速补液试验次数、 输液总量、净输液量、失血量低于晶体液组,尿量高于晶体液组,使用去甲肾上腺素比例低于晶体液组(P<0.05)。2 组患者术后30 d内总体并发症发生率和病死率比较差异无统计学意义(P>0.05)。胶体液组患者术后30 d内肺炎发 生率明显低于晶体液组(P<0.05);2组患者住院时间及住院费用比较差异无统计学意义(P>0.05)。结论 与晶体 液相比,术中目标导向的胶体液治疗能减少胃肠道手术患者术中输液量,降低术后肺炎发生率,但不能降低术后总 体并发症发生率和病死率。

关键词: 消化系统外科手术, 手术后并发症, 输注, 静脉内, 目标导向液体治疗, 晶体液, 胶体液

Abstract: Objective To evaluate the effects of crystalloid or colloid for intraoperative goal-directed fluid therapy on postoperative complications in patients undergoing gastrointestinal surgery. Methods Three hundred and sixty-two patients who were scheduled to receive open or laparoscopic gastrointestinal surgery under general anesthesia in our institution were enrolled. Patients were randomly divided into crystal solution group (n=180) and colloid solution group (n= 182). All patients had maintenance- lactated Ringer's solution administration throughout the operation period. The Vigileo/ FloTrac system was used to continuously monitor stroke volume (SV). In order to maximize SV, the two groups were treated for the goal-directed strategy. Intraoperative fluid infusion volume, blood loss, urine output and the administration of vasoactive agents were recorded. After surgery, postoperative morbidity and mortality within 30 days, hospital length of stay and hospital costs were followed. Results Numbers of bolus fluid infusion, total volume of fluid administered intraoperatively, net fluid balance, blood loss volume and the rate of norepinephrine administration were significantly lower in colloid solution group than those of crystal solution group, whereas urine output was higher in the colloid solution group (P<0.05). There were no significant differences in the overall postoperative morbidity and mortality 30 days after operation between the two groups of patients (P>0.05). There was a lower incidence of postoperative pneumonia 30 days after operation in the colloid solution group (P<0.05). There were no significant differences in the length of hospital stay and hospital costs between the two groups (P>0.05). Conclusion Compared with crystalloid, the intraoperative colloid-based goal-directed fluid therapy can reduce the intraoperative volume of fluid infusion and the incidence of postoperative pneumonia. However, it cannot reduce the overall postoperative morbidity or mortality.

Key words: digestive system surgical procedures, postoperative complications, infusions, intravenous, goal-directed fluid therapy, crystalloid, colloid

中图分类号: